Abstract: A brake operation portion that allows a manual brake operation is included in a vehicle cabin, the brake operation portion includes a grip portion, and an elbow rest member is provided at, in the vehicle rear side of the grip portion, a position on which an elbow of a driver can abut in a state in which the driver grips the grip portion so as to be capable of operating the grip portion. Thus, even a physically disabled driver may freely perform a driving operation and easily manually perform a delicate brake operation.

Abstract: An object of the present invention is to provide an aluminum phospite having spherical shape. An aluminum phosphite of the present invention has the following formula. Alx(OH)y(HPO3)3·zH2O wherein: x represents 2.01 or more and 2.50 or less, y represents 0.03 or more and 1.50 or less, and z represents an integer of 0 to 4, respectively.

Abstract: A brake operation portion that allows a manual brake operation is included in a vehicle cabin, the brake operation portion includes a grip portion, and an elbow rest member is provided at, in the vehicle rear side of the grip portion, a position on which an elbow of a driver can abut in a state in which the driver grips the grip portion so as to be capable of operating the grip portion. Thus, even a physically disabled driver may freely perform a driving operation and easily manually perform a delicate brake operation.

Abstract: An object of the present invention is to provide an aluminum phospite having spherical shape. An aluminum phosphite of the present invention has the following formula. Alx(OH)y(HPO3)3.zH2O wherein: x represents 2.01 or more and 2.50 or less, y represents 0.03 or more and 1.50 or less, and z represents an integer of 0 to 4, respectively.

Abstract: A vehicle interior structure includes a pedal-backward-preventive bracket against which a supporting portion of a control panel abuts when the control pedal controlled by a foot of a driver moves backward, the pedal-backward-preventive bracket being fixed to an instrumental panel support member extending in a vehicle width direction, a mount bracket on which a head-up display is mounted, the mount bracket being fixed to the instrumental panel support member, and a load transfer portion that is provided between the pedal-backward-preventive bracket and the mount bracket to transfer a rearward load input to the pedal-backward-preventive bracket to the mount bracket via the supporting portion.

Abstract: A vehicle interior structure includes a pedal-backward-preventive bracket against which a supporting portion of a control panel abuts when the control pedal controlled by a foot of a driver moves backward, the pedal-backward-preventive bracket being fixed to an instrumental panel support member extending in a vehicle width direction, a mount bracket on which a head-up display is mounted, the mount bracket being fixed to the instrumental panel support member, and a load transfer portion that is provided between the pedal-backward-preventive bracket and the mount bracket to transfer a rearward load input to the pedal-backward-preventive bracket to the mount bracket via the supporting portion.

Abstract: Disclosed herein are novel biomarkers for detecting resistance and sensitivity to abiraterone acetate-glucocorticoid treatment in a patient having metastatic castration resistant prostate cancer. Also provided are methods of diagnosing and treating abiraterone acetate-glucocorticoid resistant and abiraterone acetate-glucocorticoid sensitive metastatic castration resistant prostate cancer.

Abstract: The present invention provides a novel antimetabolic anticancer agent that has an excellent balance between antitumor effect and toxicity. Specifically, the present invention provides a medicament containing, as an active ingredient, a 5-fluorouracil derivative represented by Formula (I) or a salt thereof: wherein R1 represents a hydrogen atom or a protecting group of a hydroxy group, R2 represents a lower alkoxy-lower alkyl group or a tetrahydrofuranyl group, X represents a carbon atom or a nitrogen atom, and Y represents a halogen atom or a cyano group.

Abstract: The present invention provides a novel antimetabolic anticancer agent that has an excellent balance between antitumor effect and toxicity. Specifically, the present invention provides a medicament containing, as an active ingredient, a 5-fluorouracil derivative represented by Formula (I) or a salt thereof: wherein R1 represents a hydrogen atom or a protecting group of a hydroxy group, R2 represents a lower alkoxy-lower alkyl group or a tetrahydrofuranyl group, X represents a carbon atom or a nitrogen atom, and Y represents a halogen atom or a cyano group.